Check out the full article here

Check out the article here!

Shapiro et al. report preliminary proof-of concept that in 17 people with type 1diabetes, pancreatic endoderm cells in an investigational subcutaneous device (VC02) achieved engraftment and insulin expression in 63% …

We are excited to announce that promising results from an international, first-in-human clinical trial showed that the ViaCyte #stemcell derived therapy can produce insulin in people with #T1D! The results …

Read about Nina Greene’s experience receiving a transplant of islet cells.